Los Angeles, California--(Newsfile Corp. - March 28, 2024) - The Schall Law

Firm (https://api.newsfilecorp.com/redirect/gO2J3Ux8Dn), a national

shareholder rights litigation firm, reminds investors of a class action

lawsuit against agilon health, inc. ("agilon" or "the Company") (NYSE: AGL)

for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934

and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange

Commission.

Investors who purchased the Company's securities between January 9, 2023 and

January 4, 2024, inclusive (the "Class Period"), or purchased or otherwise

acquired agilon common stock pursuant, or traceable to materials issued in

connection with the Company's secondary public offering (the "SPO Materials")

that occurred on or about May 16, 2023.are encouraged to contact the firm

before May 20, 2024.

If you are a shareholder who suffered a loss, click here to participate

(https://api.newsfilecorp.com/redirect/pEAp2tRXQM).

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049

Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to

discuss your rights free of charge. You can also reach us through the firm's

website at www.schallfirm.com, or by email at bschall@schallfirm.com.

The class, in this case, has not yet been certified, and until certification

occurs, you are not represented by an attorney. If you choose to take no

action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements

to the market. The Company's purported visibility into medical costs and

utilization costs was touted by agilon's management team. The Company failed

to disclose the increased medical costs it had incurred due to higher

utilization by Healthcare MA patients. The Company falsely stated its

accounting reserves for higher utilization were adequate for its needs. The

Company issued overly optimistic guidance for financial performance. Based on

these facts, the Company's public statements were false and materially

misleading throughout the class period. When the market learned the truth

about agilon, investors suffered damages.

Join the case (https://api.newsfilecorp.com/redirect/0Vmp2fEPWK) to recover

your losses.

The Schall Law Firm represents investors around the world and specializes in

securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some

jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm

Brian Schall, Esq.,

www.schallfirm.com

Office: 310-301-3335

info@schallfirm.com

SOURCE:

The Schall Law Firm

To view the source version of this press release, please visit

https://www.newsfilecorp.com/release/203422